BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shaheen AA, Nguyen HH, Congly SE, Kaplan GG, Swain MG. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States. Liver Int. 2019;39:878-884. [PMID: 30688401 DOI: 10.1111/liv.14054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 García-Martínez R, Diaz-Ruiz R, Poncela M. Management of Hepatic Encephalopathy Associated with Advanced Liver Disease. Clin Drug Investig 2022. [PMID: 35536537 DOI: 10.1007/s40261-022-01146-6] [Reference Citation Analysis]
2 Spiewak T, Taefi A, Patel S, Li CS, Chak E. Racial disparities of Black Americans hospitalized for decompensated liver cirrhosis. BMC Gastroenterol. 2020;20:245. [PMID: 32727386 DOI: 10.1186/s12876-020-01392-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Bloom PP, Ventoso M, Tapper E, Ha J, Richter JM. A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving. Dig Dis Sci 2021. [PMID: 34018070 DOI: 10.1007/s10620-021-07013-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Bloom PP, Marx M, Wang TJ, Green B, Ha J, Bay C, Chung RT, Richter JM. Attitudes towards digital health tools for outpatient cirrhosis management in patients with decompensated cirrhosis. BMJ Innov 2020;6:18-25. [DOI: 10.1136/bmjinnov-2019-000369] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
5 Gabriel MM, Kircheis G, Hardtke S, Markwardt D, Buggisch P, Mix H, Grüngreiff K, Welzel TM, Kälsch J, Hartmann H, Gerbes AL, Karpowitz MV, Seeliger B, Wedemeyer H, Weissenborn K. Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study. European Journal of Gastroenterology & Hepatology 2021;33:1185-93. [DOI: 10.1097/meg.0000000000001822] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Çelik F, Bektaş H. Preventive and Treatment Interventions for Abdominal Ascites of Patients with Liver Cirrhosis: A Systematic Review of Randomized Controlled Trials. Florence Nightingale J Nurs 2021;29:250-62. [PMID: 34263244 DOI: 10.5152/FNJN.2021.19171] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tocia C, Dumitru A, Alexandrescu L, Popescu R, Dumitru E. Timing of paracentesis and outcomes in hospitalized patients with decompensated cirrhosis. World J Hepatol 2020; 12(12): 1267-1275 [PMID: 33442453 DOI: 10.4254/wjh.v12.i12.1267] [Reference Citation Analysis]
8 Bloom PP, Chung RT. Editorial: mind the gaps - an important first step towards improving hepatic encephalopathy care. Aliment Pharmacol Ther 2019;49:1534-5. [PMID: 31134647 DOI: 10.1111/apt.15290] [Reference Citation Analysis]
9 Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526-1547. [PMID: 33097308 DOI: 10.1016/j.jhep.2020.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
10 Bloom PP, Robin J, Xu M, Arvind A, Daidone M, Gupta AS, Chung RT. Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment. Am J Gastroenterol 2021;116:1950-3. [PMID: 34465696 DOI: 10.14309/ajg.0000000000001351] [Reference Citation Analysis]
11 Carbonneau M, Davyduke T, Congly SE, Ma MM, Newnham K, Den Heyer V, Tandon P, Abraldes JG. Impact of specialized multidisciplinary care on cirrhosis outcomes and acute care utilization. CanLivJ 2021;4:38-50. [DOI: 10.3138/canlivj-2020-0017] [Reference Citation Analysis]
12 Elsaid MI, John T, Li Y, Pentakota SR, Rustgi VK. The Health Care Burden of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:263-75. [DOI: 10.1016/j.cld.2020.01.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Xu X, Tan J, Wang H, Zhao W, Qin B. Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days. Front Med (Lausanne) 2021;8:646875. [PMID: 34136498 DOI: 10.3389/fmed.2021.646875] [Reference Citation Analysis]
14 Chirapongsathorn S, Poovorawan K, Soonthornworasiri N, Pan-Ngum W, Phaosawasdi K, Treeprasertsuk S. Thirty-Day Readmission and Cost Analysis in Patients With Cirrhosis: A Nationwide Population-Based Data. Hepatol Commun 2020;4:453-60. [PMID: 32140661 DOI: 10.1002/hep4.1472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim D, Cholankeril G, Li AA, Kim W, Tighe SP, Hameed B, Kwo PY, Harrison SA, Younossi ZM, Ahmed A. Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver Int 2019;39:1661-71. [PMID: 31081997 DOI: 10.1111/liv.14135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
16 Khan A, Maheshwari S, Gupta K, Naseem K, Chowdry M, Singh S. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement. J Gastroenterol Hepatol 2021;36:775-81. [PMID: 32710679 DOI: 10.1111/jgh.15194] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Frenette CT, Levy C, Saab S. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door. Dig Dis Sci 2021. [PMID: 34169435 DOI: 10.1007/s10620-021-07075-2] [Reference Citation Analysis]
18 Gajendran M, Umapathy C, Perisetti A, Loganathan P, Dwivedi A, Alvarado LA, Zuckerman MJ, Goyal H, Elhanafi S. Nationwide analysis of incidence and predictors of 30-day readmissions in patients with decompensated cirrhosis. Frontline Gastroenterol 2022;13:295-302. [DOI: 10.1136/flgastro-2021-101850] [Reference Citation Analysis]
19 Bloom P, Wang T, Marx M, Tagerman M, Green B, Arvind A, Ha J, Bloom J, Richter JM. A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility Study. JMIR Med Inform 2020;8:e17770. [PMID: 32876581 DOI: 10.2196/17770] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Chen Z, Babcock A, Sanogo V, Nelson DR, Xiao H, Diaby V. Predictors of 30-day readmission and hospitalization costs of patients with hepatic encephalopathy in the US from 2010 to 2014. Expert Rev Pharmacoecon Outcomes Res 2021;:1-7. [PMID: 33985399 DOI: 10.1080/14737167.2021.1927717] [Reference Citation Analysis]
21 Bajaj JS, Acharya C, Sikaroodi M, Gillevet PM, Thacker LR. Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis. GastroHep 2020;2:79-86. [PMID: 33071650 DOI: 10.1002/ygh2.390] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Patel H, Balar B, Irigela M, Vootla V, Chandrala C, Hashmi H, Abdulsamad M, Makker J. Risk Factors for Liver Cirrhosis-Related Readmissions in the Largest Ethnic Minority in United States. Gastroenterology Res 2020;13:11-8. [PMID: 32095168 DOI: 10.14740/gr1227] [Reference Citation Analysis]
23 Kabaria S, Gupta K, Bhurwal A, Patel AV, Rustgi VK. Predictors of do-not-resuscitate order utilization in decompensated cirrhosis hospitalized patients: A nationwide inpatient cohort study. Ann Hepatol 2021;22:100284. [PMID: 33160032 DOI: 10.1016/j.aohep.2020.10.012] [Reference Citation Analysis]
24 Yoder L, Mladenovic A, Pike F, Vuppalanchi R, Hanson H, Corbito L, Desai AP, Chalasani N, Orman ES. Attendance at a Transitional Liver Clinic May Be Associated with Reduced Readmissions for Patients with Liver Disease. Am J Med 2021:S0002-9343(21)00647-1. [PMID: 34655539 DOI: 10.1016/j.amjmed.2021.09.016] [Reference Citation Analysis]
25 Moon CM, Lee YY, Heo SH, Shin SS, Jeong YY. Identification of potential metabolic biomarkers in predicting esophageal varices needing treatment in patients with liver cirrhosis. Sci Rep 2021;11:19684. [PMID: 34608234 DOI: 10.1038/s41598-021-99198-9] [Reference Citation Analysis]